Johnson & Johnson MedTech Announces Labeling Amendment of LINX™ Reflux Management System in the U.S. to Include Patients With Barrett’s Esophagus Experiencing Gastroesophageal Reflux Disease
/sc-assets/prd/practices/cd555ffc-5462-4a50-9e0c-a1959d82cd14/icon_asterisk_x2.png){kind=icon}
/sc-assets/prd/practices/cd555ffc-5462-4a50-9e0c-a1959d82cd14/icon_asterisk_x2-1721918395162.png){kind=icon}
/sc-assets/prd/practices/cd555ffc-5462-4a50-9e0c-a1959d82cd14/jhonson.png)
/sc-assets/prd/practices/cd555ffc-5462-4a50-9e0c-a1959d82cd14/Surgical Weight Loss 1.jpg)
/sc-assets/prd/practices/cd555ffc-5462-4a50-9e0c-a1959d82cd14/Surgical weight loss 2.jpg)
/sc-assets/prd/practices/cd555ffc-5462-4a50-9e0c-a1959d82cd14/Surgical Weight Loss 3.jpg)
/sc-assets/prd/practices/cd555ffc-5462-4a50-9e0c-a1959d82cd14/1.png)
/sc-assets/prd/practices/cd555ffc-5462-4a50-9e0c-a1959d82cd14/2.png)
/sc-assets/prd/practices/cd555ffc-5462-4a50-9e0c-a1959d82cd14/3.png)
/sc-assets/prd/practices/cd555ffc-5462-4a50-9e0c-a1959d82cd14/4.png)